Caryophyllene sales will expand through 2036, with the liquid form holding 61.0% of the form segment in 2026. The market was valued at USD 493.80 million in 2025 and is expected to reach USD 987.18 million by 2036, creating an incremental opportunity of USD 461.28 million between 2026 and 2036.